ESPR

#2893
Esperion Therapeutics, Inc.
2.05 USD
-7.66%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
2.05
2.05
년간 변동
0.69
4.18
일일 변동
-7.66%
월간 변동
-19.29%
6달 변화
-25.18%
년간 변동율
+105.00%
이전 종가
2.22
Open
2.05
Bid
Ask
Low
2.05
High
2.05
양
63
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 526.46 M
  • Employee 294
  • Founded N/A
  • CEO Sheldon Koenig
  • Website www.esperion.com
  • Headquarter Delaware, United States
  • FIGI BBG004KB3S72
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-33.64
Price to sales ratio
1.91

Esperion Therapeutics Inc

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

뉴스